Literature DB >> 25503620

Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants.

David J Schretlen1, Mark Varvaris2, Tracy D Vannorsdall2, Barry Gordon2, James C Harris2, H A Jinnah2.   

Abstract

OBJECTIVE: We sought to examine brain white matter abnormalities based on MRI in adults with Lesch-Nyhan disease (LND) or an attenuated variant (LNV) of this rare, X-linked neurodevelopmental disorder of purine metabolism.
METHODS: In this observational study, we compared 21 adults with LND, 17 with LNV, and 33 age-, sex-, and race-matched healthy controls using voxel-based morphometry and analysis of covariance to identify white matter volume abnormalities in both patient groups.
RESULTS: Patients with classic LND showed larger reductions of white (26%) than gray (17%) matter volume relative to healthy controls. Those with LNV showed comparable reductions of white (14%) and gray (15%) matter volume. Both patient groups demonstrated reduced volume in medial inferior white matter regions. Compared with LNV, the LND group showed larger reductions in inferior frontal white matter adjoining limbic and temporal regions and the motor cortex. These regions likely include such long association fibers as the superior longitudinal and uncinate fasciculi.
CONCLUSIONS: Despite earlier reports that LND primarily involves the basal ganglia, this study reveals substantial white matter volume abnormalities. Moreover, white matter deficits are more severe than gray matter deficits in classic LND, and also characterize persons with LNV. The brain images acquired for these analyses cannot precisely localize white matter abnormalities or determine whether they involve changes in tract orientation or anisotropy. However, clusters of reduced white matter volume identified here affect regions that are consistent with the neurobehavioral phenotype.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25503620      PMCID: PMC4336080          DOI: 10.1212/WNL.0000000000001128

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice.

Authors:  D W Smith; T Friedmann
Journal:  Mol Ther       Date:  2000-05       Impact factor: 11.454

2.  Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study.

Authors:  David J Schretlen; Mark Varvaris; Tiffany E Ho; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182

Review 3.  The anatomical basis of dystonia: current view using neuroimaging.

Authors:  Stéphane Lehéricy; Marina A J Tijssen; Marie Vidailhet; Ryuji Kaji; Sabine Meunier
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 4.  Experience-dependent structural plasticity in the adult human brain.

Authors:  Arne May
Journal:  Trends Cogn Sci       Date:  2011-09-07       Impact factor: 20.229

5.  Presynaptic dopaminergic deficits in Lesch-Nyhan disease.

Authors:  M Ernst; A J Zametkin; J A Matochik; D Pascualvaca; P H Jons; K Hardy; J G Hankerson; D J Doudet; R M Cohen
Journal:  N Engl J Med       Date:  1996-06-13       Impact factor: 91.245

6.  Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  D J Schretlen; J C Harris; K S Park; H A Jinnah; N O del Pozo
Journal:  J Int Neuropsychol Soc       Date:  2001-11       Impact factor: 2.892

Review 7.  Lesch-Nyhan disease and the basal ganglia.

Authors:  J E Visser; P R Bär; H A Jinnah
Journal:  Brain Res Brain Res Rev       Date:  2000-04

8.  Dopamine metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient variants of PC12 cells.

Authors:  C M Bitler; B D Howard
Journal:  J Neurochem       Date:  1986-07       Impact factor: 5.372

Review 9.  The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.

Authors:  A A Baumeister; G D Frye
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

10.  Erosion of dosage compensation impacts human iPSC disease modeling.

Authors:  Shila Mekhoubad; Christoph Bock; A Sophie de Boer; Evangelos Kiskinis; Alexander Meissner; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

View more
  6 in total

1.  Hypoxanthine Intrastriatal Administration Alters Neuroinflammatory Profile and Redox Status in Striatum of Infant and Young Adult Rats.

Authors:  Helena Biasibetti; Paula Pierozan; André Felipe Rodrigues; Vanusa Manfredini; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-03-24       Impact factor: 5.590

Review 2.  Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.

Authors:  Khue Vu Nguyen
Journal:  AIMS Neurosci       Date:  2022-04-21

3.  Microstructural white matter abnormalities in Lesch-Nyhan disease.

Authors:  Victor A Del Bene; Jeffrey L Crawford; Ainara Gómez-Gastiasoro; Tracy D Vannorsdall; Alison Buchholz; Natalia Ojeda; James C Harris; Hyder A Jinnah; David J Schretlen
Journal:  Eur J Neurosci       Date:  2021-12-06       Impact factor: 3.698

4.  The Study on the Clinical Phenotype and Function of HPRT1 Gene.

Authors:  Miao Guo; Yucai Chen; Longlong Lin; Yilin Wang; Anqi Wang; Fang Yuan; Chunmei Wang; Simei Wang; Yuanfeng Zhang
Journal:  Child Neurol Open       Date:  2022-07-19

Review 5.  Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.

Authors:  Marta Fumagalli; Davide Lecca; Maria P Abbracchio; Stefania Ceruti
Journal:  Front Pharmacol       Date:  2017-12-19       Impact factor: 5.810

Review 6.  Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Edoardo Petrotto; Maria Grazia Tozzi
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.